---
title: "12 Health Care Stocks Moving In Wednesday's Intraday Session"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/277815476.md"
description: "In Wednesday's intraday session, Firefly Neuroscience (NASDAQ:AIFF) saw a significant gain of 62.3%, reaching $1.11, while Baird Medical Investment (NASDAQ:BDMD) rose 27.6% to $3.18. Can Fite Biopharma (AMEX:CANF) and Evolus (NASDAQ:EOLS) also experienced notable increases of 26.4% and 23.69%, respectively. Conversely, SCWorx (NASDAQ:WORX) declined by 19.3% to $0.14, and Adial Pharmaceuticals (NASDAQ:ADIL) fell 16.11% to $1.92. Other notable losers included Kazia Therapeutics (NASDAQ:KZIA) and Rigel Pharmaceuticals (NASDAQ:RIGL), which dropped 11.04% and 10.15%, respectively."
datetime: "2026-03-04T17:05:40.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/277815476.md)
  - [en](https://longbridge.com/en/news/277815476.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/277815476.md)
---

# 12 Health Care Stocks Moving In Wednesday's Intraday Session

### Gainers

-   **Firefly Neuroscience** (NASDAQ:AIFF) stock increased by 62.3% to $1.11 during Wednesday's regular session. The company's market cap stands at $9.7 million.
-   **Baird Medical Investment** (NASDAQ:BDMD) shares moved upwards by 27.6% to $3.18. The market value of their outstanding shares is at $91.4 million.
-   **Can Fite Biopharma** (AMEX:CANF) shares rose 26.4% to $6.32. The company's market cap stands at $6.5 million.
-   **Evolus** (NASDAQ:EOLS) stock rose 23.69% to $5.11. The market value of their outstanding shares is at $267.7 million. As per the press release, Q4 earnings came out yesterday.
-   **Agilon Health** (NYSE:AGL) stock moved upwards by 18.31% to $0.67. The company's market cap stands at $235.1 million.
-   **InMed Pharmaceuticals** (NASDAQ:INM) shares increased by 16.81% to $0.89. The market value of their outstanding shares is at $2.2 million.

### Losers

-   **SCWorx** (NASDAQ:WORX) shares declined by 19.3% to $0.14 during Wednesday's regular session. The market value of their outstanding shares is at $2.8 million.
-   **Adial Pharmaceuticals** (NASDAQ:ADIL) shares fell 16.11% to $1.92. The market value of their outstanding shares is at $2.5 million.
-   **Kazia Therapeutics** (NASDAQ:KZIA) shares fell 11.04% to $8.9. The market value of their outstanding shares is at $113.4 million.
-   **Rigel Pharmaceuticals** (NASDAQ:RIGL) stock declined by 10.15% to $29.67. The company's market cap stands at $592.2 million. The company's, Q4 earnings came out yesterday.
-   **ImmunityBio** (NASDAQ:IBRX) stock fell 8.75% to $9.12. The market value of their outstanding shares is at $9.8 billion.
-   **Sol-Gel Technologies** (NASDAQ:SLGL) shares fell 8.64% to $89.51. The market value of their outstanding shares is at $272.9 million. **See Also:** www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

### Related Stocks

- [XBI.US](https://longbridge.com/en/quote/XBI.US.md)
- [IHI.US](https://longbridge.com/en/quote/IHI.US.md)
- [CANF.US](https://longbridge.com/en/quote/CANF.US.md)
- [BBH.US](https://longbridge.com/en/quote/BBH.US.md)
- [AIFF.US](https://longbridge.com/en/quote/AIFF.US.md)
- [WORX.US](https://longbridge.com/en/quote/WORX.US.md)
- [ADIL.US](https://longbridge.com/en/quote/ADIL.US.md)
- [IBBQ.US](https://longbridge.com/en/quote/IBBQ.US.md)
- [EOLS.US](https://longbridge.com/en/quote/EOLS.US.md)
- [IXJ.US](https://longbridge.com/en/quote/IXJ.US.md)
- [IHE.US](https://longbridge.com/en/quote/IHE.US.md)
- [BDMD.US](https://longbridge.com/en/quote/BDMD.US.md)
- [IBB.US](https://longbridge.com/en/quote/IBB.US.md)
- [SBIO.US](https://longbridge.com/en/quote/SBIO.US.md)
- [XHE.US](https://longbridge.com/en/quote/XHE.US.md)
- [RIGL.US](https://longbridge.com/en/quote/RIGL.US.md)
- [ARKG.US](https://longbridge.com/en/quote/ARKG.US.md)
- [BIB.US](https://longbridge.com/en/quote/BIB.US.md)
- [XLV.US](https://longbridge.com/en/quote/XLV.US.md)

## Related News & Research

- [Mizuho Securities Keeps Their Buy Rating on Evolus (EOLS)](https://longbridge.com/en/news/283088175.md)
- [Danaher Corporation (NYSE:DHR) Short Interest Up 25.0% in March](https://longbridge.com/en/news/283039047.md)
- [RBC Capital Sticks to Their Buy Rating for Edwards Lifesciences (EW)](https://longbridge.com/en/news/282768248.md)
- [Roth MKM Reaffirms Their Buy Rating on Equillium (EQ)](https://longbridge.com/en/news/283066157.md)
- [Phocas Financial Corp. Takes Position in BioCryst Pharmaceuticals, Inc. $BCRX](https://longbridge.com/en/news/282977301.md)